Justice Alito Stays Discovery Order In Generic Drug Price-Fixing MDL

Mealey's (March 3, 2020, 12:12 PM EST) -- WASHINGTON, D.C. — On Feb. 28, Justice Samuel A. Alito Jr. granted an application by a group of pharmaceutical firm defendants to stay a portion of a trial court’s discovery order in a multidistrict price-fixing litigation to allow for the U.S. Supreme Court’s resolution of the firms’ petition for certiorari, in which they argue that the order improperly requires them to produce materials before they have the opportunity to object on the basis of relevance or responsiveness in violation of Federal Rule of Civil Procedure 26(b)(1) (Actavis Holdco Inc., et al. v. Connecticut, et al., No. 19-1010, U.S. Sup., 2020 U.S. LEXIS 1369)....